ClinicalTrialsFinder

Recurrent B-Cell Non-Hodgkin Lymphoma Clinical Trials in Ann Arbor, Michigan

1 recruitingAnn Arbor, Michigan

Showing 1–1 of 1 trials

Recruiting
Phase 1

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Recurrent B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaRecurrent B Acute Lymphoblastic Leukemia+1 more
University of Michigan Rogel Cancer Center12 enrolled1 locationNCT07532525